menu
    • menu

    Company profile for Lipidio Pharmaceuticals

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Lipidio, patients remain at the center of all that we do. We are focused on and passionate about bringing the very best medicines to market to help patients in need. To do this, we leverage our teams’ proven drug development track record to identify, develop and transform molecules into important medicines. We acquire molecules that we believe have unrealized therapeutic potential. We then apply our unique expertise to...
    At Lipidio, patients remain at the center of all that we do. We are focused on and passionate about bringing the very best medicines to market to help patients in need. To do this, we leverage our teams’ proven drug development track record to identify, develop and transform molecules into important medicines. We acquire molecules that we believe have unrealized therapeutic potential. We then apply our unique expertise to optimize each molecules’ preclinical and clinical development plans to enable marketing approval and/or a successful exit.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lipidio PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3570 Carmel Mountain Rd. Suite 200 San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lipidiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Food Ingredients China

    Not Confirmed

    envelop Contact Supplier

    Food Ingredients China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lipidio Pharma Appoints Renowned Experts Arne Astrup, MD
    Lipidio Pharma Appoints Renowned Experts Arne Astrup, MD

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lipidio-pharmaceuticals-expands-advisory-team-with-appointment-of-renowned-experts-arne-astrup-md-and-mark-lappe-302575482.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Metabolics biotech secures humble Series A from big-name investors
    Metabolics biotech secures humble Series A from big-name investors

    10 Nov 2022

    // Paul Schloesser ENDPTS

    https://endpts.com/metabolics-biotech-secures-humble-series-a-from-big-name-investors/

    Paul Schloesser ENDPTS
    10 Nov 2022
    Share Share
    Lipidio Pharmaceuticals Announces Close of Series A Extension Financing
    Lipidio Pharmaceuticals Announces Close of Series A Extension Financing

    10 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lipidio-pharmaceuticals-announces-close-of-series-a-extension-financing-bringing-total-round-to-over-20m-301674386.html

    PRNEWSWIRE
    10 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search